Showing results (41-50 of 507) with videos related to
Sort By:
Pageof 51
Diagnostic and Prognostic Research|December 16, 2025
A decomposition of Fisher's information to inform sample size for developing or updating fair and precise clinical prediction models - part 2: time-to-event outcomesRichard D Riley, Gary S Collins, Lucinda Archer, et al.Statistical Methods in Medical Research|July 7, 2017
A robust imputation method for missing responses and covariates in sample selection modelsEmmanuel O Ogundimu, Gary S CollinsHeart (British Cardiac Society)|June 13, 2012
Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UKGary S Collins, Douglas G AltmanEuropean Journal of Cancer (Oxford, England : 1990)|November 20, 2012
Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal)Gary S Collins, Douglas G AltmanBMJ (Clinical Research Ed.)|May 15, 2010
An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort studyGary S Collins, Douglas G AltmanCancer Epidemiology|January 3, 2013
Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction modelGary S Collins, Douglas G AltmanBMJ (Clinical Research Ed.)|July 9, 2009
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort studyGary S Collins, Douglas G AltmanThe British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 4, 2013
Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas)Gary S Collins, Douglas G AltmanBMJ (Clinical Research Ed.)|June 23, 2012
Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2Gary S Collins, Douglas G AltmanJournal of Clinical Epidemiology|April 6, 2016
Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settingsRolf H H Groenwold, Karel G M Moons, Romin Pajouheshnia, et al.Pageof 51